|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Muscle Spasticity | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Spinal Cord Injuries | |||||
| 3 | More general conditions related to this trial | ||||
| Central Nervous System Diseases | |||||
| Disorders of Environmental Origin | |||||
| Muscle Hypertonia | |||||
| Muscular Diseases | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Neuromuscular Manifestations | |||||
| Signs and Symptoms | |||||
| Spinal Cord Diseases | |||||
| Trauma, Nervous System | |||||
| Wounds and Injuries | |||||
| 4 | Interventions listed in this trial | ||||
| XP19986 | |||||
| 5 | Sponsors listed in this trial | ||||
| XenoPort, Inc. | |||||